Showing results (371-380 of 725) with videos related to
Sort By:
Pageof 73
Urology Case Reports|August 21, 2025
Augmented reality assisted MRI/US fusion for non-rectal fully trans-perineal prostate biopsyBraden Millan, Nikhil Pramod, Jaskirat Saini, et al.Annals of Hepato-Biliary-Pancreatic Surgery|December 2, 2025
Hepatic lymph node metastases in patients with colorectal liver metastases undergoing hepatic artery infusion pump placementAaron J Dinerman, Alyssa V Eade, Kyle J Hitscherich, et al.The Journal of Urology|April 5, 2017
Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group SystemSherif Mehralivand, Sandra Bednarova, Joanna H Shih, et al.Academic Radiology|September 29, 2023
Predicting 18F-DCFPyL-PET/CT Scan Positivity in Prostate Cancer Patients with Biochemical RecurrenceKaterina H Lee, Esther Mena, Joanna Shih, et al.Frontiers in Oncology|March 20, 2023
First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case reportMohammad O Atiq, Danielle M Pastor, Fatima Karzai, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profilesShaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.Radiology|October 20, 2020
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to BoneMichael Kosmin, Anwar R Padhani, Andrew Gogbashian, et al.Radiology|October 2, 2014
Robot-assisted radical prostatectomy: Multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical marginsGiuseppe Petralia, Gennaro Musi, Anwar R Padhani, et al.Journal of Pathology Informatics|May 9, 2025
Erratum to "Artificial intelligence-based tumor segmentation in mouse models of lung adenocarcinoma" [Journal of Pathology Informatics Volume 13, 2022, 100007]Alena Arlova, Chengcheng Jin, Abigail Wong-Rolle, et al.Cancer Chemotherapy and Pharmacology|December 3, 2013
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumorsWoondong Jeong, Annamaria Rapisarda, Sook Ryun Park, et al.Pageof 73